Integrated cancer networks improve compliance with national guidelines and outcomes for resectable gastric cancer

National Comprehensive Cancer Network (NCCN) guidelines recommend accurate clinical staging, perioperative therapy, and complete lymphadenectomy for patients with stage II to III gastric cancer. However, national compliance remains low. It was hypothesized that integrated cancer networks might improve compliance and outcomes within the community.

[1]  Kitty S. Chan,et al.  Evaluating Dissemination of Adequate Lymphadenectomy for Gastric Cancer in the USA , 2019, Journal of Gastrointestinal Surgery.

[2]  J. Boughey,et al.  ASO Author Reflections: A Statistical Caution Regarding Missing Clinical Stage in the National Cancer Database , 2019, Annals of Surgical Oncology.

[3]  W. Cheng,et al.  A Comprehensive Assessment of the Racial and Ethnic Disparities in the Incidence of Gastric Cancer in the United States, 1992-2014 , 2018, Cancer research and treatment : official journal of Korean Cancer Association.

[4]  M. Shabahang,et al.  Analyzing the Impact of Compliance with National Guidelines for Pancreatic Cancer Care Using the National Cancer Database , 2018, Journal of Gastrointestinal Surgery.

[5]  S. Hochwald,et al.  Disparities in major surgery for esophagogastric cancer among hospitals by case volume. , 2018, Journal of gastrointestinal oncology.

[6]  Xianglin L. Du,et al.  Racial disparities in preoperative chemotherapy use in gastric cancer patients in the United States: Analysis of the National Cancer Data Base, 2006‐2014 , 2018, Cancer.

[7]  G. Salti,et al.  Extensive Lymph Node Dissection Improves Survival among American Patients with Gastric Adenocarcinoma Treated Surgically: Analysis of the National Cancer Database , 2017, Journal of gastric cancer.

[8]  C. Hollenbeak,et al.  Timing of Adjuvant Chemotherapy and Impact on Survival for Resected Gastric Cancer , 2016, Annals of Surgical Oncology.

[9]  J. Ajani,et al.  Yield of Staging Laparoscopy and Lavage Cytology for Radiologically Occult Peritoneal Carcinomatosis of Gastric Cancer , 2016, Annals of Surgical Oncology.

[10]  D. Fraker,et al.  Multimodality Therapy Improves Survival in Resected Early Stage Gastric Cancer in the United States , 2016, Annals of Surgical Oncology.

[11]  D. Fraker,et al.  Multimodality Treatment of T4 Gastric Cancer in the United States: Utilization Trends and Impact on Survival , 2015, Annals of Surgical Oncology.

[12]  K. Hunt,et al.  Operative standards for cancer surgery , 2015 .

[13]  J. Norton,et al.  Compliance with gastric cancer guidelines is associated with improved outcomes. , 2015, Journal of the National Comprehensive Cancer Network : JNCCN.

[14]  D. Fraker,et al.  Implications of inadequate lymph node staging in resectable gastric cancer: A contemporary analysis using the National Cancer Data Base , 2014, Cancer.

[15]  D. Penson,et al.  Trends in the use of evidence‐based therapy for resectable gastric cancer , 2014, Journal of surgical oncology.

[16]  I. Choi,et al.  Prognostic Impact of Microscopic Tumor Involved Resection Margin in Advanced Gastric Cancer Patients after Gastric Resection , 2014, World Journal of Surgery.

[17]  Percy Lee,et al.  Benefit of Adjuvant Chemoradiotherapy for Gastric Adenocarcinoma: A SEER Population Analysis. , 2013, Gastrointestinal cancer research : GCR.

[18]  A. Benson,et al.  Treatment Trends and Predictors of Adjuvant and Neoadjuvant Therapy for Gastric Adenocarcinoma in the United States , 2013, Annals of Surgical Oncology.

[19]  B. Feig,et al.  Do Hospital Attributes Predict Guideline-Recommended Gastric Cancer Care in the United States? , 2012, Annals of Surgical Oncology.

[20]  A. Stewart,et al.  Variations in gastric cancer care , 2010, Cancer.

[21]  C. Ko,et al.  Using the NCDB for cancer care improvement: An introduction to available quality assessment tools , 2009, Journal of surgical oncology.

[22]  C. Ko,et al.  Effect of hospital type and volume on lymph node evaluation for gastric and pancreatic cancer. , 2008, Archives of surgery.

[23]  J. Ajani,et al.  Treatment of Gastric Adenocarcinoma May Differ Among Hospital Types in the United States, a Report from the National Cancer Data Base , 2007, Journal of Gastrointestinal Surgery.

[24]  D. Gouma,et al.  Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  D. Gouma,et al.  Extended lymph-node dissection for gastric cancer. , 1999, The New England journal of medicine.

[26]  P. Fayers,et al.  Patient survival after D 1 and D 2 resections for gastric cancer: long-term results of the MRC randomized surgical trial , 1999, British Journal of Cancer.

[27]  P. Fayers,et al.  Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial , 1996, The Lancet.

[28]  J. Hermans,et al.  Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients , 1995, The Lancet.

[29]  M. Senthil,et al.  The role of the cancer center when using lymph node count as a quality measure for gastric cancer surgery. , 2015, JAMA surgery.

[30]  L. Tanoue,et al.  The National Comprehensive Cancer Network , 1998, Cancer.

[31]  H. Putter,et al.  Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. , 2010, The Lancet. Oncology.

[32]  E. Jensen,et al.  Guideline Recommended Gastric Cancer Care in the Elderly: Insights into the Applicability of Cancer Trials to Real World , 2010, Annals of Surgical Oncology.

[33]  J. Meyerhardt,et al.  Impact of hospital procedure volume on surgical operation and long-term outcomes in high-risk curatively resected rectal cancer: findings from the Intergroup 0114 Study. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  M. Huguier,et al.  [Extended lymph-node dissection for gastric cancer]. , 1999, Chirurgie; memoires de l'Academie de chirurgie.

[35]  G. Fleuren,et al.  Surgical/pathologic-stage migration confounds comparisons of gastric cancer survival rates between Japan and Western countries. , 1995, Journal of Clinical Oncology.